151 related articles for article (PubMed ID: 31575084)
1. The YAP1-NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target.
Yoo W; Lee J; Jun E; Noh KH; Lee S; Jung D; Jung KH; Kim JS; Park YY; Kim SC; Kim S
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31575084
[TBL] [Abstract][Full Text] [Related]
2. YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Zhou Q; Bauden M; Andersson R; Hu D; Marko-Varga G; Xu J; Sasor A; Dai H; Pawłowski K; Said Hilmersson K; Chen X; Ansari D
J Transl Med; 2020 Feb; 18(1):77. PubMed ID: 32054505
[TBL] [Abstract][Full Text] [Related]
3. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
[TBL] [Abstract][Full Text] [Related]
4. Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors.
Rani S; Corcoran C; Shiels L; Germano S; Breslin S; Madden S; McDermott MS; Browne BC; O'Donovan N; Crown J; Gogarty M; Byrne AT; O'Driscoll L
Cancer Res; 2014 Jul; 74(14):3821-33. PubMed ID: 24876102
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway.
Garczyk S; Klotz N; Szczepanski S; Denecke B; Antonopoulos W; von Stillfried S; Knüchel R; Rose M; Dahl E
Oncotarget; 2017 May; 8(22):36246-36265. PubMed ID: 28423716
[TBL] [Abstract][Full Text] [Related]
6. Yes-associated protein 1 promotes bladder cancer invasion by regulating epithelial-mesenchymal transition.
Chen X; Li S; Yu Z; Tan W
Int J Clin Exp Pathol; 2019; 12(3):1070-1077. PubMed ID: 31933921
[TBL] [Abstract][Full Text] [Related]
7. YAP1 is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Pancreatic Cancer.
Sun K; Zhang XD; Liu XY; Lu P
Front Mol Biosci; 2021; 8():625731. PubMed ID: 34150844
[TBL] [Abstract][Full Text] [Related]
8. Neuromedin U secreted by colorectal cancer cells promotes a tumour-supporting microenvironment.
Przygodzka P; Soboska K; Sochacka E; Pacholczyk M; Braun M; Kassassir H; Papiewska-Pająk I; Kielbik M; Boncela J
Cell Commun Signal; 2022 Dec; 20(1):193. PubMed ID: 36482448
[TBL] [Abstract][Full Text] [Related]
9. Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression.
Guo Z; Guo L
Int J Clin Oncol; 2024 Apr; 29(4):442-455. PubMed ID: 38383698
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of gene regulation network and immune signatures of prognostic biomarker YAP1 in pancreatic cancer.
Yang Y; Zheng Y; Liu X; Ji R; Chen Z; Guo Q; Wu G; Wang Y; Zhou Y
J Cancer; 2020; 11(23):6960-6969. PubMed ID: 33123286
[No Abstract] [Full Text] [Related]
11. NMU signaling promotes endometrial cancer cell progression by modulating adhesion signaling.
Lin TY; Wu FJ; Chang CL; Li Z; Luo CW
Oncotarget; 2016 Mar; 7(9):10228-42. PubMed ID: 26849234
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein 1 as a prognostic biomarker and its correlation with telomerase in various cancers.
Kim HR; Seo CW; Yoo K; Han SJ; Kim J
Osong Public Health Res Perspect; 2021 Oct; 12(5):324-332. PubMed ID: 34719224
[TBL] [Abstract][Full Text] [Related]
14. NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein.
Guo H; Zou J; Zhou L; Zhong M; He Y; Huang S; Chen J; Li J; Xiong J; Fang Z; Xiang X
Front Oncol; 2020; 10():591698. PubMed ID: 33489890
[TBL] [Abstract][Full Text] [Related]
15. Verteporfin induced SUMOylation of YAP1 in endometrial cancer.
Wang B; Shao W; Shi Y; Liao J; Chen X; Wang C
Am J Cancer Res; 2020; 10(4):1207-1217. PubMed ID: 32368396
[TBL] [Abstract][Full Text] [Related]
16. PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis.
Wang P; Wei D; Zhang H; Chen J; Zhang D; Ganapathy S; Isakson P; Chen C; Zhu T
Oncotarget; 2018 Aug; 9(67):32736-32750. PubMed ID: 30214681
[TBL] [Abstract][Full Text] [Related]
17. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
[TBL] [Abstract][Full Text] [Related]
18. Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets.
Kaczmarek P; Malendowicz LK; Pruszynska-Oszmalek E; Wojciechowicz T; Szczepankiewicz D; Szkudelski T; Nowak KW
Int J Mol Med; 2006 Nov; 18(5):951-5. PubMed ID: 17016626
[TBL] [Abstract][Full Text] [Related]
19. [Neuromedin U expression related to the occurrence of laryngeal carcinoma and the regional lymph node metastasis].
Wang YP; Chen C; Li LX; Cui XB; Xu MY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(10):811-814. PubMed ID: 29798060
[No Abstract] [Full Text] [Related]
20. Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer.
Nambara S; Masuda T; Nishio M; Kuramitsu S; Tobo T; Ogawa Y; Hu Q; Iguchi T; Kuroda Y; Ito S; Eguchi H; Sugimachi K; Saeki H; Oki E; Maehara Y; Suzuki A; Mimori K
Oncotarget; 2017 Dec; 8(64):107666-107677. PubMed ID: 29296196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
